|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of deferred commissions | |||||
| Amortization of debt issuance costs | |||||
| Deferred income taxes | |||||
| Provision for credit losses and service credits | |||||
| Stock-based compensation expense | |||||
| Net periodic pension cost (benefit) | |||||
| Impairment charges | |||||
| (Gain) loss on foreign currency exchange rates | |||||
| Loss on early extinguishment of debt | |||||
| Loss from the remeasurement of the indemnification asset | |||||
| Bargain purchase gain | |||||
| Other, net | |||||
| Changes in working capital items, excluding acquisitions: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Prepaid expenses, deferred costs, and other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Contract liabilities | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Additions to fixed assets and capitalized software | |||||
| Proceeds from the sale of assets | |||||
| Acquisition of a business, net of cash acquired | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from Term Loan | |||||
| Term Loan | |||||
| Proceeds from Term Loan, related party | |||||
| Term Loan | |||||
| Payments of Term Loan | |||||
| Term Loan | |||||
| Senior Term Loan | |||||
| Repayments of term loan, related party | |||||
| Term Loan | |||||
| Senior Term Loan | |||||
| Proceeds from ABL Facility | |||||
| Payments of ABL Facility | |||||
| Proceeds from exercises of stock warrants | |||||
| Principal payments on finance lease obligation | |||||
| Debt issuance costs | |||||
| Repurchases of common stock | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from exercise of stock warrants | |||||
| Proceeds from common stock offering, net of offering expenses | |||||
| Other | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| (Decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental Information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net | |||||
| Non-cash investing and financing activities | |||||
| Repurchase of Treasury stock as a result of the settlement of the indemnification asset | |||||
Loading...